Φλεκαϊνίδη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Φλεκαϊνίδη" in Greek language version.

refsWebsite

Global rank Greek rank

39nih.gov

4^th place

30doi.org

2^nd place

3^rd place

9archive.org

6^th place

5^th place

4drugs.com

399^th place

130^th place

2clincalc.com

3,912^th place

594^th place

1web.archive.org

1^st place

archive.org

«Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality». Br Heart J 68 (4): 392–97. 1992. doi:10.1136/hrt.68.10.392. PMID 1449923. PMC 1025139. https://archive.org/details/sim_british-heart-journal_1992-10_68_4/page/392.
«Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I». Br Heart J 74 (6): 631–35. 1995. doi:10.1136/hrt.74.6.631. PMID 8541168. PMC 484119. https://archive.org/details/sim_british-heart-journal_1995-12_74_6/page/631.
«Life-threatening flecainide toxicity. A pharmacodynamic approach». Annals of Internal Medicine 106 (6): 807–14. 1987. doi:10.7326/0003-4819-106-6-807. PMID 3107447. https://archive.org/details/sim_annals-of-internal-medicine_1987-06_106_6/page/807.
«Life-threatening flecainide toxicity. A pharmacodynamic approach». Annals of Internal Medicine 106 (6): 807–14. 1987. doi:10.7326/0003-4819-106-6-807. PMID 3107447. https://archive.org/details/sim_annals-of-internal-medicine_1987-06_106_6/page/807. Winkelmann B, Leinberger H (1987). "Life-threatening flecainide toxicity. A pharmacodynamic approach". Annals of Internal Medicine. 106 (6): 807–14. doi:10.7326/0003-4819-106-6-807. PMID 3107447.
«Extracorporeal circulatory support in near-fatal flecainide overdose». Anaesth Intensive Care 27 (4): 405–08. 1999. doi:10.1177/0310057x9902700413. PMID 10470398. https://archive.org/details/sim_anaesthesia-and-intensive-care_1999-08_27_4/page/405.
«Flecainide overdose: is cardiopulmonary support the treatment?». Annals of Emergency Medicine 29 (5): 680–82. 1997. doi:10.1016/S0196-0644(97)70257-9. PMID 9140253. https://archive.org/details/sim_annals-of-emergency-medicine_1997-05_29_5/page/680.
«Flecainide distribution in human tissues». British Journal of Clinical Pharmacology 24 (6): 820–22. December 1987. doi:10.1111/j.1365-2125.1987.tb03252.x. PMID 3125854. PMC 1386410. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_1987-12_24_6/page/820.
«Drug-induced lung disease». Cleve Clin J Med 68 (9): 782–85, 789–95. September 2001. doi:10.3949/ccjm.68.9.782. PMID 11563482. https://archive.org/details/sim_cleveland-clinic-journal-of-medicine_2001-09_68_9/page/782.
«Pharmacodynamic variability of flecainide assessed by QRS changes». Clin Pharmacol Ther 53 (1): 59–64. 1993. doi:10.1038/clpt.1993.9. PMID 8422742. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_1993-01_53_1/page/59.

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Flecainide Acetate – Drug Usage Statistics». ClinCalc. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2021. Ανακτήθηκε στις 11 Απριλίου 2020.

doi.org

dx.doi.org

«Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality». Br Heart J 68 (4): 392–97. 1992. doi:10.1136/hrt.68.10.392. PMID 1449923. PMC 1025139. https://archive.org/details/sim_british-heart-journal_1992-10_68_4/page/392.
«Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial». N Engl J Med 324 (12): 781–88. 1991. doi:10.1056/NEJM199103213241201. PMID 1900101.
«Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I». Br Heart J 74 (6): 631–35. 1995. doi:10.1136/hrt.74.6.631. PMID 8541168. PMC 484119. https://archive.org/details/sim_british-heart-journal_1995-12_74_6/page/631.
«Flecainide test in Brugada syndrome: a reproducible but risky tool». Pacing Clin Electrophysiol 26 (1 Pt 2): 338–41. 2003. doi:10.1046/j.1460-9592.2003.00045.x. PMID 12687841.
«Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation». Eurospace 13 (2): 161–73. 2011. doi:10.1093/europace/euq382. PMID 21138930.
Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989). «Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.». N Engl J Med 321 (6): 406–12. doi:10.1056/NEJM198908103210629. PMID 2473403.
«Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia». Pacing Clin Electrophysiol 24 (1): 119–21. 2001. doi:10.1046/j.1460-9592.2001.00119.x. PMID 11227957.
Morganroth J (1992). «Early and late proarrhythmia from antiarrhythmic drug therapy». Cardiovasc Drugs Ther 6 (1): 11–14. doi:10.1007/BF00050910. PMID 1533532.
«Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function». Chest 103 (4): 1068–73. 1993. doi:10.1378/chest.103.4.1068. PMID 8131440.
«Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate». Pacing Clin Electrophysiol 25 (5): 871–72. 2002. doi:10.1046/j.1460-9592.2002.00871.x. PMID 12049386.
«Life-threatening flecainide toxicity. A pharmacodynamic approach». Annals of Internal Medicine 106 (6): 807–14. 1987. doi:10.7326/0003-4819-106-6-807. PMID 3107447. https://archive.org/details/sim_annals-of-internal-medicine_1987-06_106_6/page/807.
«Life-threatening flecainide toxicity. A pharmacodynamic approach». Annals of Internal Medicine 106 (6): 807–14. 1987. doi:10.7326/0003-4819-106-6-807. PMID 3107447. https://archive.org/details/sim_annals-of-internal-medicine_1987-06_106_6/page/807. Winkelmann B, Leinberger H (1987). "Life-threatening flecainide toxicity. A pharmacodynamic approach". Annals of Internal Medicine. 106 (6): 807–14. doi:10.7326/0003-4819-106-6-807. PMID 3107447.
«Extracorporeal circulatory support in near-fatal flecainide overdose». Anaesth Intensive Care 27 (4): 405–08. 1999. doi:10.1177/0310057x9902700413. PMID 10470398. https://archive.org/details/sim_anaesthesia-and-intensive-care_1999-08_27_4/page/405.
«Flecainide overdose: is cardiopulmonary support the treatment?». Annals of Emergency Medicine 29 (5): 680–82. 1997. doi:10.1016/S0196-0644(97)70257-9. PMID 9140253. https://archive.org/details/sim_annals-of-emergency-medicine_1997-05_29_5/page/680.
«Flecainide distribution in human tissues». British Journal of Clinical Pharmacology 24 (6): 820–22. December 1987. doi:10.1111/j.1365-2125.1987.tb03252.x. PMID 3125854. PMC 1386410. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_1987-12_24_6/page/820.
«Drug-induced lung disease». Cleve Clin J Med 68 (9): 782–85, 789–95. September 2001. doi:10.3949/ccjm.68.9.782. PMID 11563482. https://archive.org/details/sim_cleveland-clinic-journal-of-medicine_2001-09_68_9/page/782.
«Interstitial lung disease induced by drugs and radiation». Respiration 71 (4): 301–26. 2004. doi:10.1159/000079633. PMID 15316202.
«Diffuse Infiltrative Lung Disease Associated with Flecainide». Respiration 69 (2): 182–85. 2002. doi:10.1159/000056325. PMID 11961436.
«Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome». Acta Cardiol 55 (1): 45–57. February 2000. doi:10.2143/ac.55.1.2005718. PMID 10707759.
Smith G (1985). «Flecainide: a new class Ic antidysrhythmic». Drug Intell Clin Pharm 19 (10): 703–07. doi:10.1177/106002808501901001. PMID 3902429.
«Pharmacodynamic variability of flecainide assessed by QRS changes». Clin Pharmacol Ther 53 (1): 59–64. 1993. doi:10.1038/clpt.1993.9. PMID 8422742. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_1993-01_53_1/page/59.
«Potent inhibition of cytochrome P450IID6 (debrisoquin 4-hydroxylase) by flecainide in vitro and in vivo». J Cardiovasc Pharmacol 15 (5): 776–79. 1990. doi:10.1097/00005344-199005000-00013. PMID 1692938.
«Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function». Chest 103 (4): 1068–73. 1993. doi:10.1378/chest.103.4.1068. PMID 8131440. Santinelli V, Arnese M, Oppo I, Matarazzi C, Maione S, Palma M, Giunta A (1993). "Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function". Chest. 103 (4): 1068–73. doi:10.1378/chest.103.4.1068. PMID 8131440.
Abdelilah, Ghannam (2014). «Non-Accidental Flecainide Overdose, A Case Report». International Journal of Medicine and Surgery 1 (2): 53. doi:10.15342/ijms.v1i2.18.
«State-dependent trapping of flecainide in the cardiac sodium channel». J Physiol 560 (Pt 1): 37–49. 2004. doi:10.1113/jphysiol.2004.065003. PMID 15272045.
«Multiple modes of ryanodine receptor 2 inhibition by flecainide». Molecular Pharmacology 86 (6): 696–706. 2014. doi:10.1124/mol.114.094623. PMID 25274603.
«Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass». Journal of Molecular and Cellular Cardiology 48 (2): 293–301. 2010. doi:10.1016/j.yjmcc.2009.10.005. PMID 19835880.
«The direct actions of flecainide on the human cardiac ryanodine receptor: keeping open the debate on the mechanism of action of local anesthetics in CPVT». Circulation Research 116 (8): 1284–86. 2015. doi:10.1161/CIRCRESAHA.115.306298. PMID 25858058.

doi.org

«Life-threatening flecainide toxicity. A pharmacodynamic approach». Annals of Internal Medicine 106 (6): 807–14. 1987. doi:10.7326/0003-4819-106-6-807. PMID 3107447. https://archive.org/details/sim_annals-of-internal-medicine_1987-06_106_6/page/807. Winkelmann B, Leinberger H (1987). "Life-threatening flecainide toxicity. A pharmacodynamic approach". Annals of Internal Medicine. 106 (6): 807–14. doi:10.7326/0003-4819-106-6-807. PMID 3107447.
«Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function». Chest 103 (4): 1068–73. 1993. doi:10.1378/chest.103.4.1068. PMID 8131440. Santinelli V, Arnese M, Oppo I, Matarazzi C, Maione S, Palma M, Giunta A (1993). "Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function". Chest. 103 (4): 1068–73. doi:10.1378/chest.103.4.1068. PMID 8131440.

drugs.com

«Flecainide Acetate Monograph for Professionals». Drugs.com. American Society of Health-System Pharmacists. Ανακτήθηκε στις 7 Απριλίου 2019.
«Flecainide Acetate Monograph for Professionals». Drugs.com. American Society of Health-System Pharmacists. Ανακτήθηκε στις 7 Απριλίου 2019. "Flecainide Acetate Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 7 April 2019.
«Flecainide (Tambocor) Use During Pregnancy». Drugs.com (στα Αγγλικά). Ανακτήθηκε στις 7 Απριλίου 2019.
«Flecainide Acetate Monograph for Professionals». Drugs.com. American Society of Health-System Pharmacists. Ανακτήθηκε στις 7 Απριλίου 2019. "Flecainide Acetate Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 7 April 2019.

nih.gov

ncbi.nlm.nih.gov

«Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality». Br Heart J 68 (4): 392–97. 1992. doi:10.1136/hrt.68.10.392. PMID 1449923. PMC 1025139. https://archive.org/details/sim_british-heart-journal_1992-10_68_4/page/392.
«[Effects of oral flecainide treatment of refractory tachyarrhythmias]». Kokyu to Junkan 38 (5): 471–76. 1990. PMID 2115193.
«Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial». N Engl J Med 324 (12): 781–88. 1991. doi:10.1056/NEJM199103213241201. PMID 1900101.
«Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I». Br Heart J 74 (6): 631–35. 1995. doi:10.1136/hrt.74.6.631. PMID 8541168. PMC 484119. https://archive.org/details/sim_british-heart-journal_1995-12_74_6/page/631.
«Flecainide test in Brugada syndrome: a reproducible but risky tool». Pacing Clin Electrophysiol 26 (1 Pt 2): 338–41. 2003. doi:10.1046/j.1460-9592.2003.00045.x. PMID 12687841.
«Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation». Eurospace 13 (2): 161–73. 2011. doi:10.1093/europace/euq382. PMID 21138930.
Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989). «Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.». N Engl J Med 321 (6): 406–12. doi:10.1056/NEJM198908103210629. PMID 2473403.
«Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia». Pacing Clin Electrophysiol 24 (1): 119–21. 2001. doi:10.1046/j.1460-9592.2001.00119.x. PMID 11227957.
Morganroth J (1992). «Early and late proarrhythmia from antiarrhythmic drug therapy». Cardiovasc Drugs Ther 6 (1): 11–14. doi:10.1007/BF00050910. PMID 1533532.
«Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function». Chest 103 (4): 1068–73. 1993. doi:10.1378/chest.103.4.1068. PMID 8131440.
«Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate». Pacing Clin Electrophysiol 25 (5): 871–72. 2002. doi:10.1046/j.1460-9592.2002.00871.x. PMID 12049386.
«Life-threatening flecainide toxicity. A pharmacodynamic approach». Annals of Internal Medicine 106 (6): 807–14. 1987. doi:10.7326/0003-4819-106-6-807. PMID 3107447. https://archive.org/details/sim_annals-of-internal-medicine_1987-06_106_6/page/807.
«Life-threatening flecainide toxicity. A pharmacodynamic approach». Annals of Internal Medicine 106 (6): 807–14. 1987. doi:10.7326/0003-4819-106-6-807. PMID 3107447. https://archive.org/details/sim_annals-of-internal-medicine_1987-06_106_6/page/807. Winkelmann B, Leinberger H (1987). "Life-threatening flecainide toxicity. A pharmacodynamic approach". Annals of Internal Medicine. 106 (6): 807–14. doi:10.7326/0003-4819-106-6-807. PMID 3107447.
«Extracorporeal circulatory support in near-fatal flecainide overdose». Anaesth Intensive Care 27 (4): 405–08. 1999. doi:10.1177/0310057x9902700413. PMID 10470398. https://archive.org/details/sim_anaesthesia-and-intensive-care_1999-08_27_4/page/405.
«Flecainide overdose: is cardiopulmonary support the treatment?». Annals of Emergency Medicine 29 (5): 680–82. 1997. doi:10.1016/S0196-0644(97)70257-9. PMID 9140253. https://archive.org/details/sim_annals-of-emergency-medicine_1997-05_29_5/page/680.
«Flecainide distribution in human tissues». British Journal of Clinical Pharmacology 24 (6): 820–22. December 1987. doi:10.1111/j.1365-2125.1987.tb03252.x. PMID 3125854. PMC 1386410. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_1987-12_24_6/page/820.
«Drug-induced lung disease». Cleve Clin J Med 68 (9): 782–85, 789–95. September 2001. doi:10.3949/ccjm.68.9.782. PMID 11563482. https://archive.org/details/sim_cleveland-clinic-journal-of-medicine_2001-09_68_9/page/782.
«Interstitial lung disease induced by drugs and radiation». Respiration 71 (4): 301–26. 2004. doi:10.1159/000079633. PMID 15316202.
«Diffuse Infiltrative Lung Disease Associated with Flecainide». Respiration 69 (2): 182–85. 2002. doi:10.1159/000056325. PMID 11961436.
«[Interstitial pneumopathy due to flecainide]». Presse Med 30 (21): 1062. 2001. PMID 11471279.
«Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome». Acta Cardiol 55 (1): 45–57. February 2000. doi:10.2143/ac.55.1.2005718. PMID 10707759.
Smith G (1985). «Flecainide: a new class Ic antidysrhythmic». Drug Intell Clin Pharm 19 (10): 703–07. doi:10.1177/106002808501901001. PMID 3902429.
«Pharmacodynamic variability of flecainide assessed by QRS changes». Clin Pharmacol Ther 53 (1): 59–64. 1993. doi:10.1038/clpt.1993.9. PMID 8422742. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_1993-01_53_1/page/59.
«Potent inhibition of cytochrome P450IID6 (debrisoquin 4-hydroxylase) by flecainide in vitro and in vivo». J Cardiovasc Pharmacol 15 (5): 776–79. 1990. doi:10.1097/00005344-199005000-00013. PMID 1692938.
«Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function». Chest 103 (4): 1068–73. 1993. doi:10.1378/chest.103.4.1068. PMID 8131440. Santinelli V, Arnese M, Oppo I, Matarazzi C, Maione S, Palma M, Giunta A (1993). "Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function". Chest. 103 (4): 1068–73. doi:10.1378/chest.103.4.1068. PMID 8131440.
«State-dependent trapping of flecainide in the cardiac sodium channel». J Physiol 560 (Pt 1): 37–49. 2004. doi:10.1113/jphysiol.2004.065003. PMID 15272045.
«Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue». J Pharmacol Exp Ther 267 (2): 575–81. 1993. PMID 8246130.
«Multiple modes of ryanodine receptor 2 inhibition by flecainide». Molecular Pharmacology 86 (6): 696–706. 2014. doi:10.1124/mol.114.094623. PMID 25274603.
«Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass». Journal of Molecular and Cellular Cardiology 48 (2): 293–301. 2010. doi:10.1016/j.yjmcc.2009.10.005. PMID 19835880.
«The direct actions of flecainide on the human cardiac ryanodine receptor: keeping open the debate on the mechanism of action of local anesthetics in CPVT». Circulation Research 116 (8): 1284–86. 2015. doi:10.1161/CIRCRESAHA.115.306298. PMID 25858058.

pubmedcentral.nih.gov

«Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality». Br Heart J 68 (4): 392–97. 1992. doi:10.1136/hrt.68.10.392. PMID 1449923. PMC 1025139. https://archive.org/details/sim_british-heart-journal_1992-10_68_4/page/392.
«Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I». Br Heart J 74 (6): 631–35. 1995. doi:10.1136/hrt.74.6.631. PMID 8541168. PMC 484119. https://archive.org/details/sim_british-heart-journal_1995-12_74_6/page/631.
«Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation». Eurospace 13 (2): 161–73. 2011. doi:10.1093/europace/euq382. PMID 21138930.
«Flecainide distribution in human tissues». British Journal of Clinical Pharmacology 24 (6): 820–22. December 1987. doi:10.1111/j.1365-2125.1987.tb03252.x. PMID 3125854. PMC 1386410. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_1987-12_24_6/page/820.
«State-dependent trapping of flecainide in the cardiac sodium channel». J Physiol 560 (Pt 1): 37–49. 2004. doi:10.1113/jphysiol.2004.065003. PMID 15272045.
«Multiple modes of ryanodine receptor 2 inhibition by flecainide». Molecular Pharmacology 86 (6): 696–706. 2014. doi:10.1124/mol.114.094623. PMID 25274603.
«Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass». Journal of Molecular and Cellular Cardiology 48 (2): 293–301. 2010. doi:10.1016/j.yjmcc.2009.10.005. PMID 19835880.

pubmed.ncbi.nlm.nih.gov

«Life-threatening flecainide toxicity. A pharmacodynamic approach». Annals of Internal Medicine 106 (6): 807–14. 1987. doi:10.7326/0003-4819-106-6-807. PMID 3107447. https://archive.org/details/sim_annals-of-internal-medicine_1987-06_106_6/page/807. Winkelmann B, Leinberger H (1987). "Life-threatening flecainide toxicity. A pharmacodynamic approach". Annals of Internal Medicine. 106 (6): 807–14. doi:10.7326/0003-4819-106-6-807. PMID 3107447.
«Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function». Chest 103 (4): 1068–73. 1993. doi:10.1378/chest.103.4.1068. PMID 8131440. Santinelli V, Arnese M, Oppo I, Matarazzi C, Maione S, Palma M, Giunta A (1993). "Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function". Chest. 103 (4): 1068–73. doi:10.1378/chest.103.4.1068. PMID 8131440.

web.archive.org

«Flecainide Acetate – Drug Usage Statistics». ClinCalc. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2021. Ανακτήθηκε στις 11 Απριλίου 2020.